慢性淋巴细胞白血病的免疫疗法
Brian Sworder1, Tanya Siddiqi2
1Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA 91010, USA.
Hematology/oncology clinics of North America
|July 9, 2025
概括
新型免疫疗法,包括单克隆抗体和CAR T细胞疗法,正在改变慢性淋巴细胞白血病 (CLL) 和小淋巴细胞淋巴瘤 (SLL) 的治疗方法. 本综述详细介绍了它们的演变及其在治疗这些淋巴瘤方面的有效性.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 慢性淋巴细胞白血病 (CLL) 和小淋巴细胞淋巴瘤 (SLL) 是B细胞恶性瘤.
- 传统的治疗方法有局限性,需要新的治疗方法.
研究的目的:
- 审查CLL/SLL免疫疗法的进展.
- 评估新兴免疫疗法在治疗这些血液癌症方面的疗效.
主要方法:
- 关于基于免疫的治疗方法的文献综述.
- 对单克隆抗体,双特异性抗体和CAR T细胞治疗的临床试验数据的分析.
- 综合当前关于治疗演变和疗效的证据.
主要成果:
- 单克隆抗体在CLL/SLL治疗中显示出显著的疗效.
- 双特异性抗体为免疫参与提供了一个新的机制.
- 化学抗原受体 (CAR) T细胞疗法为耐火病例提供了一个有希望的前沿.
结论:
- 基于免疫的疗法代表了CLL/SLL管理中的范式转变.
- 这些新型药物显示出显著的临床益处和改善的结果.
- 持续的研究对于优化淋巴细胞恶性瘤免疫治疗策略至关重要.
相关概念视频
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
275
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
275


